ACHILLES THERAPEUTICS PL-ADR
1 day chart
Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.
Sign up and fund a new Wall St account and get a full U.S. share.
T&Cs apply
About ACHL
Achilles Therapeutics plc is a United Kingdom-based clinical-stage biopharmaceutical company. The Company has been developing artificial intelligence (AI)-powered precision T cell therapies targeting clonal neoantigens: protein markers unique to the individual that are expressed on the surface of every cancer cell. The Company has used DNA sequencing data from each patient, together with its proprietary PELEUS bioinformatics platform, to identify clonal neoantigens specific to that patient, to enable and support development of product candidates specifically targeting those clonal neoantigens.
Find out what a historical investment in ACHILLES THERAPEUTICS PL-ADR would be worth today using our ACHL stock calculator.
-
-
-
-
-
-
-
-
-
Ready to start your investing journey with Stake?
Open an accountACHL FAQs
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in ACHL
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in ACHL
on Stake
Buy ACHL from US$3 brokerage
Invest in 9,500+ U.S. stocks and ETFs
Own a slice of ACHL from only US$10 with fractional shares
